MYNZ
Price
$1.61
Change
-$0.07 (-4.17%)
Updated
Sep 5, 04:51 PM (EDT)
Capitalization
7.46M
68 days until earnings call
STXS
Price
$2.90
Change
+$0.13 (+4.71%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
264.1M
61 days until earnings call
Interact to see
Advertisement

MYNZ vs STXS

Header iconMYNZ vs STXS Comparison
Open Charts MYNZ vs STXSBanner chart's image
Mainz Biomed
Price$1.61
Change-$0.07 (-4.17%)
Volume$951
Capitalization7.46M
Stereotaxis
Price$2.90
Change+$0.13 (+4.71%)
Volume$1.96K
Capitalization264.1M
MYNZ vs STXS Comparison Chart in %
Loading...
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MYNZ vs. STXS commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYNZ is a Hold and STXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (MYNZ: $1.63 vs. STXS: $2.90)
Brand notoriety: MYNZ and STXS are both not notable
MYNZ represents the Medical Specialties, while STXS is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MYNZ: 18% vs. STXS: 95%
Market capitalization -- MYNZ: $7.46M vs. STXS: $264.1M
MYNZ [@Medical Specialties] is valued at $7.46M. STXS’s [@Pharmaceuticals: Other] market capitalization is $264.1M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.68B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MYNZ’s FA Score shows that 1 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • MYNZ’s FA Score: 1 green, 4 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both MYNZ and STXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MYNZ’s TA Score shows that 6 TA indicator(s) are bullish while STXS’s TA Score has 5 bullish TA indicator(s).

  • MYNZ’s TA Score: 6 bullish, 4 bearish.
  • STXS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MYNZ is a better buy in the short-term than STXS.

Price Growth

MYNZ (@Medical Specialties) experienced а -2.98% price change this week, while STXS (@Pharmaceuticals: Other) price change was +0.69% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +8.25%, and the average quarterly price growth was +13.64%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

MYNZ is expected to report earnings on Nov 13, 2025.

STXS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STXS($264M) has a higher market cap than MYNZ($7.46M). STXS YTD gains are higher at: 21.053 vs. MYNZ (-61.111). STXS has more cash in the bank: 6.97M vs. MYNZ (978K). STXS has less debt than MYNZ: STXS (5.73M) vs MYNZ (8.27M).
MYNZSTXSMYNZ / STXS
Capitalization7.46M264M3%
EBITDAN/A-22.41M-
Gain YTD-61.11121.053-290%
P/E RatioN/AN/A-
RevenueN/A31.8M-
Total Cash978K6.97M14%
Total Debt8.27M5.73M144%
FUNDAMENTALS RATINGS
STXS: Fundamental Ratings
STXS
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
60
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MYNZSTXS
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 16 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KIROY6.150.30
+5.13%
Kumba Iron Ore Ltd.
RHEP1.890.09
+4.89%
Regional Health Properties, Inc.
LTGHF0.79N/A
N/A
Life Healthcare Group Holdings Ltd
DNZOF15.07N/A
N/A
Denso Corp.
MHIVF0.09N/A
N/A
Invesque Inc.

MYNZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYNZ has been loosely correlated with ACRS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MYNZ jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNZ
1D Price
Change %
MYNZ100%
+1.20%
ACRS - MYNZ
40%
Loosely correlated
+0.49%
CHEK - MYNZ
27%
Poorly correlated
-3.92%
STXS - MYNZ
25%
Poorly correlated
+1.85%
SINT - MYNZ
23%
Poorly correlated
-17.36%
BLFS - MYNZ
23%
Poorly correlated
+3.31%
More

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with TWST. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
+1.85%
TWST - STXS
37%
Loosely correlated
-1.42%
SMTI - STXS
34%
Loosely correlated
+1.58%
PSNL - STXS
33%
Loosely correlated
+4.95%
VCYT - STXS
33%
Poorly correlated
+2.94%
RGEN - STXS
33%
Poorly correlated
+3.79%
More